Impact of an information campaign on cardiovascular risk factors: 5- year results from Epernon, France;Influence d'une campagne d'information sur les facteurs de risque cardio-vasculaire: Epernon ville d'etude, resultats a 5 ans

Presse Medicale

Volumn 28, Issue 10, 1999, Pages 517-522

  Bruckert, E ^a   Thomas, D ^a   Emmerich, J ^b   Blin, P ^c   Bichon, L ^c   Amelineau, E ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL BROUSSAIS   (France)

^c Groupe Hospitalier Pitié ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FEMALE; FRANCE; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; QUESTIONNAIRE; RISK FACTOR; SMOKING CESSATION;

ADULT; AGED; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EVALUATION STUDIES; EXERCISE; FEMALE; FRANCE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; NUTRITION PHYSIOLOGY; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 0033551012     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kannel WB, MC Gee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38:46-51.
2. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded ? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986 ; 256:2823-8.
3. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987 ; 257:2176-80.
4. Ducimetière P, Richard J, Claude JR, Warnet JM, Les cardiopathies ischémiques. Incidence et facteurs de risque. L'étude prospective parisienne. Paris, Editions INSERM, 1981.
5. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results I. Reduction in incidence of coronary heart disease. JAMA 1984 ; 251:351-64.
6. Hypertension Detection Follow-up Program Cooperative Group. Blood pressure studies in fourteen communities. A two stage screen for hypertension. JAMA 1977 ; 237:2385-91.
7. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970 ; 213:1143-52.
8. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995 ; 333:1301-7.
9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (45). Lancet 1994 ; 344:1383-9.
10. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996 ; 335:1001-9.
11. Assessing the odds. Lancet 1997 ; 350:1563.
12. Nieto FJ, Alonso J, Chambless LE et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med 1995 ; 155:677-84.
13. Bruckert E, Emmerich J, Thomas D, Charpak Y, Bichon L, Clergeot A. Influence d'une campagne d'information sur les facteurs de risque cardio-vasculaire dans une ville française (Epernon, Ville d'Etude), Méthodologie et résultats préliminaires : prévalence et niveau des facteurs de risque. Rev Epidémiol et Santé Publ 1994 ; 42:128-37.
14. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionnals. Circulation 1991 ; 83:356-62.
15. Laurier D, Chau NP, Cazelles B, Segond P and the PCV-METRA Group. Estimation of CHD risk in a French working population using a modified Framingham model. J Clin Epidemiol 1994 ; 47:1353-64.
16. Salonen JT, Puska P, Kottke TE, Tuomilehto J. Changes in smoking serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program. The North Karelia Project. Am J Epidemiol 1981 ; 114:81-94
17. Puska P, Salonen JT, Nissinen A et al. Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia Project). Br Med J Clin Res 1983 ; 287:1840-4.
18. Tuomilehto J, Geboers J, Salonen JT, Nissinen A, Kuulasmaa K, Puska P. Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J Clin Res 1986 ; 293:1068-71.
19. Farquhar JW, Maccoby N, Wood PD et al. Community education for cardiovascular health. Lancet 1977 ; 1:1192-5.
20. Fortmann SP, Williams PT, Hulley SB, Haskell WL, Farquhar JW. Effect of health education on dietary behavior: the Stanford Three Community Study Am J Clin Nutr 1981 ; 34:2030-8.
21. Farquhar JW, Fortmann SP, Maccoby N et al. The Stanford Five-City Project: design and methods. Am J Epidemiol 1985 ; 122:323-34.
22. Farquhar JW, Fortmann SP, Flora JA et al. Effects of community-wide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA 1990 ; 264:359-65.
23. Fortmann SP, Taylor CB, Flora JA, Winkleby MA. Effect of community health education on plasma cholesterol levels and diet: The Stanford Five-City Project. Am J Epidemiol 1993 ; 137:1039-55.